生物股份
(600201)
| 流通市值：135.29亿 | | | 总市值：135.29亿 |
| 流通股本：11.00亿 | | | 总股本：11.00亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 756,440,407.6 | 346,463,052.95 | 1,396,413,685.47 | 1,042,405,531.87 |
| 营业收入 | 756,440,407.6 | 346,463,052.95 | 1,396,413,685.47 | 1,042,405,531.87 |
| 二、营业总成本 | 612,971,608.14 | 269,670,737.42 | 1,278,271,814.19 | 907,899,347.17 |
| 营业成本 | 348,614,661.87 | 161,166,635.21 | 648,887,448.43 | 480,738,766.8 |
| 税金及附加 | 17,624,592.59 | 6,043,048.46 | 23,362,705.58 | 14,143,677.97 |
| 销售费用 | 146,549,592.4 | 53,979,864.03 | 335,424,429.52 | 220,622,691.54 |
| 管理费用 | 74,043,577.8 | 38,810,816.95 | 189,579,715.83 | 134,381,613.4 |
| 研发费用 | 48,365,966.66 | 20,627,231.74 | 131,087,459.56 | 96,015,120.05 |
| 财务费用 | -22,226,783.18 | -10,956,858.97 | -50,069,944.73 | -38,002,522.59 |
| 其中:利息费用 | 26,909.3 | 47,362.31 | 470,251.54 | 375,065.18 |
| 其中:利息收入 | 22,415,312.31 | 11,077,915.29 | 51,170,911.87 | 38,994,533.91 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -8,066,590.98 | -1,270,384.44 | -1,982,093.84 | 1,511,244.77 |
| 加:投资收益 | -14,700,590.2 | -449,817.94 | -2,028,932.74 | 16,516,192.29 |
| 资产处置收益 | 62,755.69 | - | 8,381,813.12 | 8,391,965.63 |
| 资产减值损失(新) | -13,215,448.97 | 3,799,523.02 | -18,598,461.87 | -2,600,444.29 |
| 信用减值损失(新) | -14,244,440.03 | -3,761,264.7 | -50,816,636.88 | -13,453,504.16 |
| 其他收益 | 37,430,251.55 | 22,428,591.19 | 51,673,680.93 | 34,447,656.97 |
| 四、营业利润 | 130,734,736.52 | 97,538,962.66 | 104,771,240 | 179,319,295.91 |
| 加:营业外收入 | 997,326.58 | 45,803.41 | 377,357.87 | 199,800.79 |
| 减:营业外支出 | 1,102,684.56 | 898,559.06 | 528,701.26 | 355,329.82 |
| 五、利润总额 | 130,629,378.54 | 96,686,207.01 | 104,619,896.61 | 179,163,766.88 |
| 减:所得税费用 | 19,200,856.85 | 14,987,666.28 | 9,113,587.29 | 19,964,963.83 |
| 六、净利润 | 111,428,521.69 | 81,698,540.73 | 95,506,309.32 | 159,198,803.05 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 111,428,521.69 | 81,698,540.73 | 95,506,309.32 | 159,198,803.05 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 104,100,301.02 | 80,643,017.03 | 100,111,637.71 | 161,312,813.38 |
| 少数股东损益 | 7,328,220.67 | 1,055,523.7 | -4,605,328.39 | -2,114,010.33 |
| 扣除非经常损益后的净利润 | 89,685,647.91 | 64,486,287.26 | 49,744,333.97 | 114,837,411.65 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.1 | 0.07 | 0.09 | 0.15 |
| (二)稀释每股收益 | 0.1 | - | - | 0.15 |
| 八、其他综合收益 | -2,284.37 | -1,188.9 | 60,380,493.99 | 95,422,007.86 |
| 归属于母公司股东的其他综合收益 | -2,284.37 | -1,188.9 | 60,249,293.4 | 95,452,764.53 |
| 九、综合收益总额 | 111,426,237.32 | 81,697,351.83 | 155,886,803.31 | 254,620,810.91 |
| 归属于母公司股东的综合收益总额 | 104,098,016.65 | 80,641,828.13 | 160,360,931.11 | 256,765,577.91 |
| 归属于少数股东的综合收益总额 | 7,328,220.67 | 1,055,523.7 | -4,474,127.8 | -2,144,767 |
| 公告日期 | 2026-08-04 | 2026-04-23 | 2026-04-23 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |